Veracyte Inc (VCYT) stock news · P/E 31, rev $517.1M
Veracyte Inc (VCYT) is a diagnostics & research company listed on NASDAQ.
This VCYT news page leads with what Veracyte Inc filed — not a scraped headline mill.
No cached 8-K sentence for VCYT yet. We will not pad this page with generic market recap.
Latest reported VCYT revenue for 2025-12-31 was $517.1M. Net income was $66.4M. Revenue was up 16.0% from 2024-12-31 to 2025-12-31. VCYT currently screens at market cap $4.09B and trailing P/E 30.8.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VCYT stock page; for the tape open the quote page.
VCYT stock news FAQ
What are VCYT's latest revenue and net income?
Latest cached Veracyte Inc (VCYT) revenue for Dec 31, 2025 was $517.1M. Net income was $66.4M. Statements: https://lician.com/financials/vcyt
How did VCYT revenue change from the prior cached period?
Cached Veracyte Inc (VCYT) revenue was up 16.0% from $445.8M (Dec 31, 2024) to $517.1M (Dec 31, 2025). Statements: https://lician.com/financials/vcyt
What is VCYT's P/E ratio?
Veracyte Inc (VCYT) trailing P/E is 30.8 on the latest cached fundamentals snapshot.
What is VCYT's market cap?
Veracyte Inc (VCYT) market cap is $4.09B on the latest cached fundamentals snapshot.
What kind of company is VCYT?
Veracyte Inc (VCYT) is a diagnostics & research company listed on NASDAQ.
Where is VCYT stock news listed?
Cached stock news for Veracyte Inc (VCYT) is listed at https://lician.com/news/vcyt. Filings: https://lician.com/sec/vcyt
Not investment advice.